Show simple item record

dc.contributor.supervisorStenhouse, Elizabeth
dc.contributor.authorPaisey, Rosamund May
dc.contributor.otherFaculty of Healthen_US
dc.date.accessioned2014-08-12T15:53:20Z
dc.date.available2014-08-12T15:53:20Z
dc.date.issued2014
dc.identifier708355en_US
dc.identifier.urihttp://hdl.handle.net/10026.1/3076
dc.descriptionFull version unavailable due to 3rd party copyright restrictions.
dc.description.abstract

Incretin analogue therapies are a valuable recent treatment option for type 2 diabetes (T2D) as they can improve blood glucose control and aid weight loss. The way in which an individual recognises and responds to changes in satiety signals induced by these treatments may explain why individual response is variable. Purposive sampling of individuals with successful outcome of incretin analogue therapy (GLP-1) for T2D gathered a participant cohort 15 people with 37 years (448 months) combined experience of this treatment and 149 years of living with diabetes. The focus group data reported in this thesis, explores their experiences, the differing relationship with food and varying strategies used to accommodate the incretin effect. The insightful contributions of living with T2D and integrating GLP-1 treatment into lifestyle will likely be applicable to a wider group, as the thoughts and experiences of the study participants should inform advice to people living with T2D considering GLP-1 treatment and those encountering difficulties after its introduction. The three broad themes which emerged from analysis: 1) The experience of ‘A Changed Relationship to Food and Eating’ set in context with links and interactions to both 2) ‘The Medical Experience’ and 3) ‘Social, Cultural and Emotional Influences’ are discussed in the context of existing evidence. The physical, social and emotional aspects of living with diabetes and the wider issues of how changed food and eating practices, have impacted on a generation and links with obesity and chronic disease risk are also explored.

en_US
dc.language.isoenen_US
dc.publisherPlymouth Universityen_US
dc.subjectType 2 diabetesen_US
dc.subjectQualitative researchen_US
dc.subjectGlucagon-like peptide-1 (GLP-1) agonistsen_US
dc.subjectFood and eating practicesen_US
dc.subjectSocial, cultural and emotional influencesen_US
dc.subjectAppetiteen_US
dc.subjectPortion sizeen_US
dc.subjectAdapting to changes in satietyen_US
dc.subjectPatient lived experienceen_US
dc.titleExploring the Patient Experience of Changes in Appetite and Diet with Incretin Analogue Therapyen_US
dc.typeMastersen_US
plymouth.versionEdited versionen_US


Files in this item

Thumbnail
Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record


All items in PEARL are protected by copyright law.
Author manuscripts deposited to comply with open access mandates are made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or document. In the absence of an open licence (e.g. Creative Commons), permissions for further reuse of content should be sought from the publisher or author.
Theme by 
Atmire NV